Washington, February 9: Johnson and Johnson (JNJ) has finally got a green signal from The Food and Drug Administration (FDA), to market a device that could be a potential cure for the common heart-rhythm disorder called atrial fibrillation. This is the first ever approval given by the FDA for a device of this kind.